Dietary agents in cancer prevention: An immunological perspective

Photochemistry and Photobiology

Volumn 88, Issue 5, 2012, Pages 1083-1098

  Zheng, Ya Ying ^a   Viswanathan, Bharathi ^a   Kesarwani, Pravin ^a   Mehrotra, Shikhar ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; PROANTHOCYANIDIN; RESVERATROL; STILBENE DERIVATIVE;

ADAPTIVE IMMUNITY; CARCINOMA; CONFERENCE PAPER; DIET; DRUG EFFECT; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE; MELANOMA; RADIATION EXPOSURE; SKIN; SKIN TUMOR; ULTRAVIOLET RADIATION;

ADAPTIVE IMMUNITY; BIOLOGICAL AGENTS; CARCINOMA; CATECHIN; DIET; HUMANS; IMMUNITY, INNATE; LYMPHOCYTES; MELANOMA; PROANTHOCYANIDINS; SKIN; SKIN NEOPLASMS; STILBENES; ULTRAVIOLET RAYS;

ARACHIS HYPOGAEA; VITACEAE;

EID: 84865961784     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2012.01128.x     Document Type: Conference Paper

References (151)

1. Kelloff, G. J., C. C. Sigman, K. M. Johnson, C. W. Boone, P. Greenwald, J. A. Crowell, E. T. Hawk, and, L. A. Doody, (2000) Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer. Cancer Epidemiol. Biomarkers Prev. 9, 127-137. (Pubitemid 30111934)
2. Richmond, E., and, J. L. Viner, (2003) Chemoprevention of skin cancer. Semin. Oncol. Nurs. 19, 62-69. (Pubitemid 40941065)
3. Narayanan, D. L., R. N. Saladi, and, J. L. Fox, (2010) Ultraviolet radiation and skin cancer. Int. J. Dermatol. 49, 978-986.
4. Katiyar, S. K., (2007) UV-induced immune suppression and photocarcinogenesis: Chemoprevention by dietary botanical agents. Cancer Lett. 255, 1-11. (Pubitemid 47212603)
5. Afaq, F., and, S. K. Katiyar, (2011) Polyphenols: Skin photoprotection and inhibition of photocarcinogenesis. Mini Rev. Med. Chem. 11, 1200-1215.
6. Stoitzner, P., C. H. Tripp, A. Eberhart, K. M. Price, J. Y. Jung, L. Bursch, F. Ronchese, and, N. Romani, (2006) Langerhans cells cross-present antigen derived from skin. Proc. Natl Acad. Sci. U.S.A. 103, 7783-7788.
7. Berger, C. L., J. G. Vasquez, J. Shofner, K. Mariwalla, and, R. L. Edelson, (2006) Langerhans cells: Mediators of immunity and tolerance. Int. J. Biochem. Cell Biol. 38, 1632-1636. (Pubitemid 43947648)
8. Lewis, J., R. Filler, D. A. Smith, K. Golubets, and, M. Girardi, (2010) The contribution of Langerhans cells to cutaneous malignancy. Trends Immunol. 31, 460-466.
9. Elyaman, W., E. M. Bradshaw, C. Uyttenhove, V. Dardalhon, A. Awasthi, J. Imitola, E. Bettelli, M. Oukka, J. van Snick, J. C. Renauld, V. K. Kuchroo, and, S. J. Khoury, (2009) IL-9 induces differentiation of TH17 cells and enhances function of FoxP3 + natural regulatory T cells. Proc. Natl Acad. Sci. U.S.A. 106, 12885-12890.
10. Noelle, R. J., and, E. C. Nowak, (2010) Cellular sources and immune functions of interleukin-9. Nat. Rev. Immunol. 10, 683-687.
11. Staudt, V., E. Bothur, M. Klein, K. Lingnau, S. Reuter, N. Grebe, B. Gerlitzki, M. Hoffmann, A. Ulges, C. Taube, N. Dehzad, M. Becker, M. Stassen, A. Steinborn, M. Lohoff, H. Schild, E. Schmitt, and, T. Bopp, (2010) Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33, 192-202.
12. Jameson, J., and, W. L. Havran, (2007) Skin gammadelta T-cell functions in homeostasis and wound healing. Immunol. Rev. 215, 114-122. (Pubitemid 46212234)
13. O'Brien, R. L., C. L. Roark, N. Jin, M. K. Aydintug, J. D. French, J. L. Chain, J. M. Wands, M. Johnston, and, W. K. Born, (2007) Gammadelta T-cell receptors: Functional correlations. Immunol. Rev. 215, 77-88. (Pubitemid 46212231)
14. Girardi, M., D. E. Oppenheim, C. R. Steele, J. M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R. E. Tigelaar, and, A. C. Hayday, (2001) Regulation of cutaneous malignancy by gammadelta T cells. Science 294, 605-609. (Pubitemid 32999559)
15. Atkins, M. B., (2006) Cytokine-based therapy and biochemotherapy for advanced melanoma. Clin. Cancer Res. 12, 2353s-2358s.
16. Krahenbuhl, O., S. Gattesco, and, J. Tschopp, (1992) Murine Thy-1+ dendritic epidermal T cell lines express granule-associated perforin and a family of granzyme molecules. Immunobiology 184, 392-401.
17. Murugaiyan, G., and, B. Saha, (2009) Protumor vs antitumor functions of IL-17. J. Immunol. 183, 4169-4175.
18. Shojaei, H., H. H. Oberg, M. Juricke, L. Marischen, M. Kunz, C. Mundhenke, F. Gieseler, D. Kabelitz, and, D. Wesch, (2009) Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells. Cancer Res. 69, 8710-8717.
19. Dudda, J. C., N. Perdue, E. Bachtanian, and, D. J. Campbell, (2008) Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J. Exp. Med. 205, 1559-1565.
20. Sather, B. D., P. Treuting, N. Perdue, M. Miazgowicz, J. D. Fontenot, A. Y. Rudensky, and, D. J. Campbell, (2007) Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204, 1335-1347. (Pubitemid 46919872)
21. Tomura, M., T. Honda, H. Tanizaki, A. Otsuka, G. Egawa, Y. Tokura, H. Waldmann, S. Hori, J. G. Cyster, T. Watanabe, Y. Miyachi, O. Kanagawa, and, K. Kabashima, (2010) Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J. Clin. Invest. 120, 883-893.
22. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and, F. Powrie, (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004.
23. Ermann, J., V. Szanya, G. S. Ford, V. Paragas, C. G. Fathman, and, K. Lejon, (2001) CD4(+)CD25(+) T cells facilitate the induction of T cell anergy. J. Immunol. 167, 4271-4275. (Pubitemid 32954301)
24. Nakamura, K., A. Kitani, and, W. Strober, (2001) Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194, 629-644. (Pubitemid 32844773)
25. Grohmann, U., C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, A. Falorni, P. Candeloro, M. L. Belladonna, R. Bianchi, M. C. Fioretti, and, P. Puccetti, (2002) CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3, 1097-1101. (Pubitemid 35363664)
26. Onishi, Y., Z. Fehervari, T. Yamaguchi, and, S. Sakaguchi, (2008) Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl Acad. Sci. U.S.A. 105, 10113-10118.
27. Loser, K., A. Mehling, S. Loeser, J. Apelt, A. Kuhn, S. Grabbe, T. Schwarz, J. M. Penninger, and, S. Beissert, (2006) Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 12, 1372-1379. (Pubitemid 44924495)
28. Yoshiki, R., K. Kabashima, J. Sakabe, K. Sugita, T. Bito, M. Nakamura, B. Malissen, and, Y. Tokura, (2010) The mandatory role of IL-10-producing and OX40 ligand-expressing mature Langerhans cells in local UVB-induced immunosuppression. J. Immunol. 184, 5670-5677.
29. Netea, M. G., R. Sutmuller, C. Hermann, C. A. Van der Graaf, J. W. Van der Meer, J. H. van Krieken, T. Hartung, G. Adema, and, B. J. Kullberg, (2004) Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172, 3712-3718. (Pubitemid 38337955)
30. Sutmuller, R. P., M. H. den Brok, M. Kramer, E. J. Bennink, L. W. Toonen, B. J. Kullberg, L. A. Joosten, S. Akira, M. G. Netea, and, G. J. Adema, (2006) Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116, 485-494. (Pubitemid 43228366)
31. Huang, B., P. Y. Pan, Q. Li, A. I. Sato, D. E. Levy, J. Bromberg, C. M. Divino, and, S. H. Chen, (2006) Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66, 1123-1131. (Pubitemid 43165981)
32. Kusmartsev, S., and, D. I. Gabrilovich, (2005) STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J. Immunol. 174, 4880-4891.
33. Curtsinger, J. M., D. C. Lins, and, M. F. Mescher, (2003) Signal 3 determines tolerance versus full activation of naive CD8 T cells: Dissociating proliferation and development of effector function. J. Exp. Med. 197, 1141-1151. (Pubitemid 36570069)
34. Lanzavecchia, A., (1999) Three signals and a master switch in the regulation of T-cell immunity. Cold Spring Harb. Symp. Quant. Biol. 64, 253-257. (Pubitemid 30329286)
35. Steinman, R. M., D. Hawiger, and, M. C. Nussenzweig, (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711. (Pubitemid 37174545)
36. Gerlini, G., A. Tun-Kyi, C. Dudli, G. Burg, N. Pimpinelli, and, F. O. Nestle, (2004) Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am. J. Pathol. 165, 1853-1863. (Pubitemid 39578365)
37. Rabinovich, G. A., D. Gabrilovich, and, E. M. Sotomayor, (2007) Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25, 267-296. (Pubitemid 46697910)
38. Ziegler, A., A. Jonason, J. Simon, D. Leffell, and, D. E. Brash, (1996) Tumor suppressor gene mutations and photocarcinogenesis. Photochem. Photobiol. 63, 432-435. (Pubitemid 126468316)
39. Ullrich, S. E., (2002) Photoimmune suppression and photocarcinogenesis. Front. Biosci. 7, d684-d703.
40. Nghiem, D. X., N. Kazimi, D. L. Mitchell, A. A. Vink, H. N. Ananthaswamy, M. L. Kripke, and, S. E. Ullrich, (2002) Mechanisms underlying the suppression of established immune responses by ultraviolet radiation. J. Invest. Dermatol. 119, 600-608.
41. Weill, F. S., E. M. Cela, A. Ferrari, M. L. Paz, J. Leoni, and, D. H. Gonzalez Maglio, (2011) Skin exposure to chronic but not acute UV radiation affects peripheral T-cell function. J. Toxicol. Environ. Health A 74, 838-847.
42. Walterscheid, J. P., S. E. Ullrich, and, D. X. Nghiem, (2002) Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J. Exp. Med. 195, 171-179. (Pubitemid 34461261)
43. Wolf, P., D. X. Nghiem, J. P. Walterscheid, S. Byrne, Y. Matsumura, C. Bucana, H. N. Ananthaswamy, and, S. E. Ullrich, (2006) Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. Am. J. Pathol. 169, 795-805. (Pubitemid 44411947)
44. Byrne, S. N., C. Beaugie, C. O'Sullivan, S. Leighton, and, G. M. Halliday, (2011) The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. Am. J. Pathol. 179, 211-222.
45. Ananthaswamy, H. N., and, W. E. Pierceall, (1990) Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem. Photobiol. 52, 1119-1136.
46. Melnikova, V. O., and, H. N. Ananthaswamy, (2005) Cellular and molecular events leading to the development of skin cancer. Mutat. Res. 571, 91-106. (Pubitemid 40313435)
47. Ouedraogo, M., C. Charles, I. P. Guissou, C. Stevigny, and, P. Duez, (2011) An overview of cancer chemopreventive potential and safety of proanthocyanidins. Nutr. Cancer 63, 1163-1173.
48. Ammon, H. P., and, M. A. Wahl, (1991) Pharmacology of Curcuma longa. Planta Med. 57, 1-7.
49. Arbiser, J. L., N. Klauber, R. Rohan, R. van Leeuwen, M. T. Huang, C. Fisher, E. Flynn, and, H. R. Byers, (1998) Curcumin is an in vivo inhibitor of angiogenesis. Mol. Med. 4, 376-383. (Pubitemid 28387896)
50. Aziz, M. H., R. Kumar, and, N. Ahmad, (2003) Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms (review). Int. J. Oncol. 23, 17-28.
51. Birt, D. F., D. Mitchell, B. Gold, P. Pour, and, H. C. Pinch, (1997) Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res. 17, 85-91. (Pubitemid 27116649)
52. Bors, W., and, M. Saran, (1987) Radical scavenging by flavonoid antioxidants. Free Radic. Res. Commun. 2, 289-294.
53. Chan, W. H., C. C. Wu, and, J. S. Yu, (2003) Curcumin inhibits UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermoid carcinoma A431 cells. J. Cell. Biochem. 90, 327-338.
54. Engelbrecht, A. M., M. Mattheyse, B. Ellis, B. Loos, M. Thomas, R. Smith, S. Peters, C. Smith, and, K. Myburgh, (2007) Proanthocyanidin from grape seeds inactivates the PI3-kinase/PKB pathway and induces apoptosis in a colon cancer cell line. Cancer Lett. 258, 144-153. (Pubitemid 47600495)
55. Fremont, L., (2000) Biological effects of resveratrol. Life Sci. 66, 663-673.
56. Gupta, S., F. Afaq, and, H. Mukhtar, (2002) Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene 21, 3727-3738. (Pubitemid 34620536)
57. Han, C., and, Y. Xu, (1990) The effect of Chinese tea on occurrence of esophageal tumor induced by N-nitrosomethylbenzylamine in rats. Biomed. Environ. Sci. 3, 35-42.
58. Hergenhahn, M., U. Soto, A. Weninger, A. Polack, C. H. Hsu, A. L. Cheng, and, F. Rosl, (2002) The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells. Mol. Carcinog. 33, 137-145. (Pubitemid 34195194)
59. Ikezaki, S., A. Nishikawa, F. Furukawa, K. Kudo, H. Nakamura, K. Tamura, and, H. Mori, (2001) Chemopreventive effects of curcumin on glandular stomach carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine and sodium chloride in rats. Anticancer Res. 21, 3407-3411. (Pubitemid 34224244)
60. Jang, M., L. Cai, G. O. Udeani, K. V. Slowing, C. F. Thomas, C. W. Beecher, H. H. Fong, N. R. Farnsworth, A. D. Kinghorn, R. G. Mehta, R. C. Moon, and, J. M. Pezzuto, (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220. (Pubitemid 127696281)
61. Jee, S. H., S. C. Shen, C. R. Tseng, H. C. Chiu, and, M. L. Kuo, (1998) Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J. Invest. Dermatol. 111, 656-661.
62. Jian, L., (2009) Soy, isoflavones, and prostate cancer. Mol. Nutr. Food Res. 53, 217-226.
63. Jiang, C., R. Agarwal, and, J. Lu, (2000) Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: Inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells. Biochem. Biophys. Res. Commun. 276, 371-378.
64. John, F., (1999) Current knowledge of the health benefits and disadvantages of wine consumption. Trends Food Sci. Tech. 10, 129-138.
65. Katiyar, S. K., R. Agarwal, M. T. Zaim, and, H. Mukhtar, (1993) Protection against N-nitrosodiethylamine and benzo[a]pyrene-induced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis 14, 849-855. (Pubitemid 23169136)
66. Katiyar, S. K., N. J. Korman, H. Mukhtar, and, R. Agarwal, (1997) Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J. Natl Cancer Inst. 89, 556-566. (Pubitemid 27172945)
67. Khan, N., F. Afaq, M. Saleem, N. Ahmad, and, H. Mukhtar, (2006) Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3- gallate. Cancer Res. 66, 2500-2505.
68. Kolodziej, H., C. Haberland, H. J. Woerdenbag, and, A. W. T. Konings, (1995) Moderate cytotoxicity of proanthocyanidins to human tumour cell lines. Phytother. Res. 9, 410-415.
69. Kwon, J. Y., K. W. Lee, J. E. Kim, S. K. Jung, N. J. Kang, M. K. Hwang, Y. S. Heo, A. M. Bode, Z. Dong, and, H. J. Lee, (2009) Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase. Carcinogenesis 30, 1932-1940.
70. Kwon, Y., and, B. A. Magnuson, (2009) Age-related differential responses to curcumin-induced apoptosis during the initiation of colon cancer in rats. Food Chem. Toxicol. 47, 377-385.
71. Latruffe, N., D. Delmas, B. Jannin, M. Cherkaoui Malki, P. Passilly-Degrace, and, J. P. Berlot, (2002) Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent. Int. J. Mol. Med. 10, 755-760.
72. Liu, L. Z., J. Fang, Q. Zhou, X. Hu, X. Shi, and, B. H. Jiang, (2005) Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: Implication of chemoprevention of lung cancer. Mol. Pharmacol. 68, 635-643. (Pubitemid 41206017)
73. Miean, K. H., and, S. Mohamed, (2001) Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J. Agric. Food Chem. 49, 3106-3112. (Pubitemid 32826116)
74. Mittal, A., C. A. Elmets, and, S. K. Katiyar, (2003) Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: Relationship to decreased fat and lipid peroxidation. Carcinogenesis 24, 1379-1388. (Pubitemid 37038827)
75. Mnich, C. D., K. S. Hoek, L. V. Virkki, A. Farkas, C. Dudli, E. Laine, M. Urosevic, and, R. Dummer, (2009) Green tea extract reduces induction of p53 and apoptosis in UVB-irradiated human skin independent of transcriptional controls. Exp. Dermatol. 18, 69-77.
76. Nandakumar, V., T. Singh, and, S. K. Katiyar, (2008) Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett. 269, 378-387.
77. Ozbay, T., and, R. Nahta, (2011) Delphinidin inhibits HER2 and Erk1/2 signaling and suppresses growth of HER2-overexpressing and triple negative breast cancer cell lines. Breast Cancer (Auckl.) 5, 143-154.
78. Patel, D., S. Shukla, and, S. Gupta, (2007) Apigenin and cancer chemoprevention: Progress, potential and promise (review). Int. J. Oncol. 30, 233-245.
79. Saito, N., K. Toki, S. Ozden, and, T. Honda, (1996) Acylated delphinidin glycosides in the blue-violet flowers of Consolida armeniaca. Phytochemistry 41, 1599-1605.
80. Shukla, Y., and, R. Singh, (2011) Resveratrol and cellular mechanisms of cancer prevention. Ann. N.Y. Acad. Sci. 1215, 1-8.
81. Stuart, E. C., M. J. Scandlyn, and, R. J. Rosengren, (2006) Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci. 79, 2329-2336. (Pubitemid 44772933)
82. Surh, Y., (1999) Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 428, 305-327. (Pubitemid 29389702)
83. Tatsuzawa, F., T. Ando, N. Saito, T. Kanaya, H. Kokubun, Y. Tsunashima, H. Watanabe, G. Hashimoto, R. Hara, and, H. Seki, (2000) Acylated delphinidin 3-rutinoside-5-glucosides in the flowers of Petunia reitzii. Phytochemistry 54, 913-917.
84. Thiruchenduran, M., N. A. Vijayan, J. K. Sawaminathan, and, S. N. Devaraj, (2011) Protective effect of grape seed proanthocyanidins against cholesterol cholic acid diet-induced hypercholesterolemia in rats. Cardiovasc. Pathol. 20, 361-368.
85. Toki, K., N. Saito, K. Iimura, T. Suzuki, and, T. Honda, (1994) (Delphinidin 3-gentiobiosyl) (apigenin 7-glucosyl) malonate from the flowers of Eichhornia crassipes. Phytochemistry 36, 1181-1183. (Pubitemid 2118455)
86. Ullah, M. F., A. Ahmad, H. Zubair, H. Y. Khan, Z. Wang, F. H. Sarkar, and, S. M. Hadi, (2010) Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen species. Mol. Nutr. Food Res. 55, 553-559.
87. Wang, I. K., S. Y. Lin-Shiau, and, J. K. Lin, (1999) Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur. J. Cancer 35, 1517-1525.
88. Wang, Y., X. Zhang, M. Lebwohl, V. DeLeo, and, H. Wei, (1998) Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein. Carcinogenesis 19, 649-654. (Pubitemid 28376809)
89. Wang, Z. Y., M. T. Huang, T. Ferraro, C. Q. Wong, Y. R. Lou, K. Reuhl, M. Iatropoulos, C. S. Yang, and, A. H. Conney, (1992) Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res. 52, 1162-1170.
90. Wang, Z. Y., M. T. Huang, C. T. Ho, R. Chang, W. Ma, T. Ferraro, K. R. Reuhl, C. S. Yang, and, A. H. Conney, (1992) Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res. 52, 6657-6665.
91. Way, T. D., M. C. Kao, and, J. K. Lin, (2004) Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 279, 4479-4489.
92. Way, T. D., M. C. Kao, and, J. K. Lin, (2005) Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells. FEBS Lett. 579, 145-152.
93. Yamane, T., N. Hagiwara, M. Tateishi, S. Akachi, M. Kim, J. Okuzumi, Y. Kitao, M. Inagake, K. Kuwata, and, T. Takahashi, (1991) Inhibition of azoxymethane-induced colon carcinogenesis in rat by green tea polyphenol fraction. Jpn. J. Cancer Res. 82, 1336-1339.
94. Zheng, P. W., L. C. Chiang, and, C. C. Lin, (2005) Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sci. 76, 1367-1379.
95. Kris-Etherton, P. M., K. D. Hecker, A. Bonanome, S. M. Coval, A. E. Binkoski, K. F. Hilpert, A. E. Griel, and, T. D. Etherton, (2002) Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 113 (Suppl. 9B), 71S-88S. (Pubitemid 36151834)
96. Park, E. J., and, J. M. Pezzuto, (2002) Botanicals in cancer chemoprevention. Cancer Metastasis Rev. 21, 231-255. (Pubitemid 36071912)
97. Jagetia, G. C., and, B. B. Aggarwal, (2007) "Spicing up" of the immune system by curcumin. J. Clin. Immunol. 27, 19-35.
98. Zhang, Y., T. W. Kensler, C. G. Cho, G. H. Posner, and, P. Talalay, (1994) Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl Acad. Sci. U.S.A. 91, 3147-3150. (Pubitemid 24130192)
99. Olszewska, M., (2008) Separation of quercetin, sexangularetin, kaempferol and isorhamnetin for simultaneous HPLC determination of flavonoid aglycones in inflorescences, leaves and fruits of three Sorbus species. J. Pharm. Biomed. Anal. 48, 629-635.
100. Scheller, S., T. Wilczok, S. Imielski, W. Krol, J. Gabrys, and, J. Shani, (1990) Free radical scavenging by ethanol extract of propolis. Int. J. Radiat. Biol. 57, 461-465. (Pubitemid 20106371)
101. Katiyar, S. K., (2005) Silymarin and skin cancer prevention: Anti-inflammatory, antioxidant and immunomodulatory effects (Review). Int. J. Oncol. 26, 169-176.
102. Tu, C. T., B. Han, Q. Y. Yao, Y. A. Zhang, H. C. Liu, and, S. C. Zhang, (2011) Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression. Int. Immunopharmacol. 12, 151-157.
103. Forward, N. A., D. M. Conrad, M. R. Power Coombs, C. D. Doucette, S. J. Furlong, T. J. Lin, and, D. W. Hoskin, (2011) Curcumin blocks interleukin (IL)-2 signaling in T-lymphocytes by inhibiting IL-2 synthesis, CD25 expression, and IL-2 receptor signaling. Biochem. Biophys. Res. Commun. 407, 801-806.
104. Luo, F., X. Song, Y. Zhang, and, Y. Chu, (2011) Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity. Int. Immunopharmacol. 11, 1234-1240.
105. Bhattacharyya, S., D. Md Sakib Hossain, S. Mohanty, G. Sankar Sen, S. Chattopadhyay, S. Banerjee, J. Chakraborty, K. Das, D. Sarkar, T. Das, and, G. Sa, (2010) Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts. Cell. Mol. Immunol. 7, 306-315.
106. Xie, L., X. K. Li, N. Funeshima-Fuji, H. Kimura, Y. Matsumoto, Y. Isaka, and, S. Takahara, (2009) Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int. Immunopharmacol. 9, 575-581.
107. Rogers, N. M., S. Kireta, and, P. T. Coates, (2010) Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo. Clin. Exp. Immunol. 162, 460-473.
108. Cong, Y., L. Wang, A. Konrad, T. Schoeb, and, C. O. Elson, (2009) Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells. Eur. J. Immunol. 39, 3134-3146.
109. Yoneyama, S., K. Kawai, N. H. Tsuno, Y. Okaji, M. Asakage, T. Tsuchiya, J. Yamada, E. Sunami, T. Osada, J. Kitayama, K. Takahashi, and, H. Nagawa, (2008) Epigallocatechin gallate affects human dendritic cell differentiation and maturation. J. Allergy Clin. Immunol. 121, 209-214.
110. Ahn, S. C., G. Y. Kim, J. H. Kim, S. W. Baik, M. K. Han, H. J. Lee, D. O. Moon, C. M. Lee, J. H. Kang, B. H. Kim, Y. H. Oh, and, Y. M. Park, (2004) Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB. Biochem. Biophys. Res. Commun. 313, 148-155.
111. Camouse, M. M., D. S. Domingo, F. R. Swain, E. P. Conrad, M. S. Matsui, D. Maes, L. Declercq, K. D. Cooper, S. R. Stevens, and, E. D. Baron, (2009) Topical application of green and white tea extracts provides protection from solar-simulated ultraviolet light in human skin. Exp. Dermatol. 18, 522-526.
112. Katiyar, S. K., and, H. Mukhtar, (2001) Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress. J. Leukoc. Biol. 69, 719-726. (Pubitemid 32466409)
113. Kang, T. H., J. H. Lee, C. K. Song, H. D. Han, B. C. Shin, S. I. Pai, C. F. Hung, C. Trimble, J. S. Lim, T. W. Kim, and, T. C. Wu, (2007) Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. Cancer Res. 67, 802-811. (Pubitemid 46192221)
114. Rogers, J., I. Perkins, A. van Olphen, N. Burdash, T. W. Klein, and, H. Friedman, (2005) Epigallocatechin gallate modulates cytokine production by bone marrow-derived dendritic cells stimulated with lipopolysaccharide or muramyldipeptide, or infected with Legionella pneumophila. Exp. Biol. Med. (Maywood) 230, 645-651. (Pubitemid 41506859)
115. Meeran, S. M., S. K. Mantena, C. A. Elmets, and, S. K. Katiyar, (2006) (-)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair. Cancer Res. 66, 5512-5520. (Pubitemid 43844980)
116. Vayalil, P. K., A. Mittal, Y. Hara, C. A. Elmets, and, S. K. Katiyar, (2004) Green tea polyphenols prevent ultraviolet light-induced oxidative damage and matrix metalloproteinases expression in mouse skin. J. Invest. Dermatol. 122, 1480-1487. (Pubitemid 38757231)
117. Mittal, A., C. Piyathilake, Y. Hara, and, S. K. Katiyar, (2003) Exceptionally high protection of photocarcinogenesis by topical application of (-)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: Relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia 5, 555-565. (Pubitemid 38045092)
118. Mantena, S. K., A. M. Roy, and, S. K. Katiyar, (2005) Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors. Photochem. Photobiol. 81, 1174-1179. (Pubitemid 41545942)
119. Bayer, J., A. Gomer, Y. Demir, H. Amano, D. D. Kish, R. Fairchild, and, P. S. Heeger, (2004) Effects of green tea polyphenols on murine transplant-reactive T cell immunity. Clin. Immunol. 110, 100-108. (Pubitemid 38177425)
120. Vaid, M., T. Singh, A. Li, N. Katiyar, S. Sharma, C. A. Elmets, H. Xu, and, S. K. Katiyar, (2011) Proanthocyanidins inhibit UV-induced immunosuppression through IL-12-dependent stimulation of CD8+ effector T cells and inactivation of CD4+ T cells. Cancer Prev. Res. (Phila.) 4, 238-247.
121. Park, M. K., J. S. Park, M. L. Cho, H. J. Oh, Y. J. Heo, Y. J. Woo, Y. M. Heo, M. J. Park, H. S. Park, S. H. Park, H. Y. Kim, and, J. K. Min, (2011) Grape seed proanthocyanidin extract (GSPE) differentially regulates Foxp3(+) regulatory and IL-17(+) pathogenic T cell in autoimmune arthritis. Immunol. Lett. 135, 50-58.
122. Yoshioka, Y., H. Akiyama, M. Nakano, T. Shoji, T. Kanda, Y. Ohtake, T. Takita, R. Matsuda, and, T. Maitani, (2008) Orally administered apple procyanidins protect against experimental inflammatory bowel disease in mice. Int. Immunopharmacol. 8, 1802-1807.
123. Bereswill, S., M. Munoz, A. Fischer, R. Plickert, L. M. Haag, B. Otto, A. A. Kuhl, C. Loddenkemper, U. B. Gobel, and, M. M. Heimesaat, (2010) Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS ONE 5, e15099.
124. Hushmendy, S., L. Jayakumar, A. B. Hahn, D. Bhoiwala, D. L. Bhoiwala, and, D. R. Crawford, (2009) Select phytochemicals suppress human T-lymphocytes and mouse splenocytes suggesting their use in autoimmunity and transplantation. Nutr. Res. 29, 568-578.
125. Baliga, M. S., and, S. K. Katiyar, (2006) Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem. Photobiol. Sci. 5, 243-253. (Pubitemid 43228052)
126. Wu, Y., L. L. Jia, Y. N. Zheng, X. G. Xu, Y. J. Luo, B. Wang, J. Z. Chen, X. H. Gao, H. D. Chen, M. Matsui, and, Y. H. Li, (2012) Resveratrate protects human skin from damage due to repetitive ultraviolet irradiation. J. Eur. Acad. Dermatol. Venereol., doi:10.1111/j.14683083.2011.04414.x.
127. Svajger, U., N. Obermajer, and, M. Jeras, (2010) Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation. Immunology 129, 525-535.
128. Feng, Y. H., Y. N. Zhu, J. Liu, Y. X. Ren, J. Y. Xu, Y. F. Yang, X. Y. Li, and, J. P. Zou, (2004) Differential regulation of resveratrol on lipopolysacchride-stimulated human macrophages with or without IFN-gamma pre-priming. Int. Immunopharmacol. 4, 713-720. (Pubitemid 38595528)
129. Sharma, S., K. Chopra, S. K. Kulkarni, and, J. N. Agrewala, (2007) Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clin. Exp. Immunol. 147, 155-163. (Pubitemid 44915567)
130. Wu, S. L., L. Yu, X. Y. Jiao, K. W. Meng, and, C. E. Pan, (2006) The suppressive effect of resveratrol on protein kinase C theta in peripheral blood T lymphocytes in a rat liver transplantation model. Transplant. Proc. 38, 3052-3054. (Pubitemid 44737948)
131. Singh, U. P., N. P. Singh, B. Singh, L. J. Hofseth, D. D. Taub, R. L. Price, M. Nagarkatti, and, P. S. Nagarkatti, (2012) Role of resveratrol-induced CD11b(+) Gr-1(+) myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3(+) T cells and amelioration of chronic colitis in IL-10(-/-) mice. Brain Behav. Immun. 26, 72-82.
132. Petro, T. M., (2011) Regulatory role of resveratrol on Th17 in autoimmune disease. Int. Immunopharmacol. 11, 310-318.
133. Yang, Y., J. H. Paik, D. Cho, J. A. Cho, and, C. W. Kim, (2008) Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells. Int. Immunopharmacol. 8, 542-547.
134. Feng, Y. H., J. P. Zou, and, X. Y. Li, (2002) Effects of resveratrol and ethanol on production of pro-inflammatory factors from endotoxin activated murine macrophages. Acta Pharmacol. Sin. 23, 1002-1006.
135. Wong, Y. T., J. Gruber, A. M. Jenner, F. E. Tay, and, R. Ruan, (2011) Chronic resveratrol intake reverses pro-inflammatory cytokine profile and oxidative DNA damage in ageing hybrid mice. Age (Dordr.) 33, 229-246.
136. Gharagozloo, M., E. Velardi, S. Bruscoli, M. Agostini, M. Di Sante, V. Donato, Z. Amirghofran, and, C. Riccardi, (2010) Silymarin suppress CD4+ T cell activation and proliferation: Effects on NF-kappaB activity and IL-2 production. Pharmacol. Res. 61, 405-409.
137. Gharagozloo, M., and, Z. Amirghofran, (2007) Effects of silymarin on the spontaneous proliferation and cell cycle of human peripheral blood leukemia T cells. J. Cancer Res. Clin. Oncol. 133, 525-532. (Pubitemid 46955680)
138. Johnson, V. J., Q. He, M. F. Osuchowski, and, R. P. Sharma, (2003) Physiological responses of a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice: III. Silymarin inhibits T-lymphocyte function at low doses but stimulates inflammatory processes at high doses. Planta Med. 69, 44-49. (Pubitemid 36228456)
139. Lee, J. S., S. G. Kim, H. K. Kim, T. H. Lee, Y. I. Jeong, C. M. Lee, M. S. Yoon, Y. J. Na, D. S. Suh, N. C. Park, I. H. Choi, G. Y. Kim, Y. H. Choi, H. Y. Chung, and, Y. M. Park, (2007) Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells. J. Cell. Physiol. 210, 385-397. (Pubitemid 44956884)
140. Min, K., W. K. Yoon, S. K. Kim, and, B. H. Kim, (2007) Immunosuppressive effect of silibinin in experimental autoimmune encephalomyelitis. Arch. Pharm. Res. 30, 1265-1272.
141. Mantovani, A., M. A. Cassatella, C. Costantini, and, S. Jaillon, (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11, 519-531.
142. Martin, F., and, A. C. Chan, (2006) B cell immunobiology in disease: Evolving concepts from the clinic. Annu. Rev. Immunol. 24, 467-496.
143. Martinez, F. O., L. Helming, and, S. Gordon, (2009) Alternative activation of macrophages: An immunologic functional perspective. Annu. Rev. Immunol. 27, 451-483.
144. Shi, F. D., H. G. Ljunggren, A. La Cava, and, L. Van Kaer, (2011) Organ-specific features of natural killer cells. Nat. Rev. Immunol. 11, 658-671.
145. Gordon, S., (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35. (Pubitemid 37328697)
146. Albini, A., and, M. B. Sporn, (2007) The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer 7, 139-147. (Pubitemid 46160989)
147. Anand, P., H. B. Nair, B. Sung, A. B. Kunnumakkara, V. R. Yadav, R. R. Tekmal, and, B. B. Aggarwal, (2010) Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem. Pharmacol. 79, 330-338.
148. Manju, S., and, K. Sreenivasan, (2011) Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability. J. Colloid Interface Sci. 359, 318-325.
149. Wan, S., Y. Sun, X. Qi, and, F. Tan, (2011) Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion. AAPS PharmSciTech. 13, 159-166.
150. Johnson, J. J., M. Nihal, I. A. Siddiqui, C. O. Scarlett, H. H. Bailey, H. Mukhtar, and, N. Ahmad, (2011) Enhancing the bioavailability of resveratrol by combining it with piperine. Mol. Nutr. Food Res. 55, 1169-1176.
151. Kudo, C., H. Yamakoshi, A. Sato, H. Ohori, C. Ishioka, Y. Iwabuchi, and, H. Shibata, (2011) Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma. Anticancer Res. 31, 3719-3726.